biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Sangamo

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Mar 01, 2023 1:51pm

86 Views

Post# 35313033

RE:RE:RE:RE:Sangamo

First of all, I no longer have the faith and admiration you have for Saltarelli, poof. He approved the Midatech sellout and he was going to go with Biodexa. He gets a lot and Bioasis get next to nothing.

He's no friend to shareholders but let's just say that he has poor judgement about deals and leave it at that for the moment.

I'm not surprised about the degree to which you can buy into propaganda without due consideration, poof. Maybe you should read the stuff you copy/paste and then think about it some.

jd

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale